VectivBio Ownership 2024 | Who Owns VectivBio Now?


OverviewForecastChart

Institutional Ownership

67.47%

Insider Ownership

4.50%

Retail Ownership

28.03%

Institutional Holders

53.00

VectivBio Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CANAAN PARTNERS XI LLC0.10%0.23%37,051--315,304,000Mar 31, 2023
CHI ADVISORS LLC0.01%11.87%5,255,484-237,409-4.32%44,724,170,000Mar 31, 2023
ORBIMED ADVISORS LLC0.01%0.86%5,156,561-1,850,300-26.41%43,882,334,000Mar 31, 2023
CITADEL ADVISORS LLC0.01%0.01%3,967,537-298-0.01%34,120,818,000Mar 31, 2023
EVENTIDE ASSET MANAGEMENT, LLC0.01%0.58%3,675,644270,0007.93%31,610,538,000Mar 31, 2023
NOVO HOLDINGS A/S0.01%2.03%3,610,461270,9778.11%30,725,023,000Mar 31, 2023
TCG CROSSOVER MANAGEMENT, LLC0.01%5.16%3,113,600780,30033.44%26,496,736,000Mar 31, 2023
BPIFRANCE SA0.01%0.61%2,806,217--23,880,907,000Mar 31, 2023
CORMORANT ASSET MANAGEMENT, LP0.01%1.42%2,536,617--21,587,000Mar 31, 2023
VIVO CAPITAL, LLC0.01%1.38%2,333,300--19,856,383,000Mar 31, 2023
VR ADVISER, LLC0.00%3.10%1,866,000--15,879,660,000Mar 31, 2023
DRIEHAUS CAPITAL MANAGEMENT LLC0.00%0.21%1,768,19851,5423.00%15,206,503,000Mar 31, 2023
MARSHALL WACE, LLP0.00%0.03%1,669,656300,00021.90%14,359,042,000Mar 31, 2023
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.0.00%0.84%1,352,19918,7991.41%11,628,911,000Mar 31, 2023
BLACKSTONE INC.0.00%0.05%1,333,333--11,466,664,000Mar 31, 2023
TEKLA CAPITAL MANAGEMENT LLC0.00%0.22%682,834-54,870-7.44%5,872,372,000Mar 31, 2023
ADAGE CAPITAL PARTNERS GP, L.L.C.0.00%0.01%409,100409,100100.00%3,481,441,000Mar 31, 2023
BALYASNY ASSET MANAGEMENT L.P.0.00%0.01%322,418-20,866-6.08%2,772,795,000Mar 31, 2023
CAXTON CORP0.00%3.40%156,6514290.27%1,345,549,000Mar 31, 2023
PFM HEALTH SCIENCES, LP0.00%0.05%131,922106,381416.51%1,122,656,000Mar 31, 2023

VectivBio's largest institutional shareholder is CANAAN PARTNERS XI LLC, holding 0.10% of the company's total share outstanding, currently valued at $315.30M. The top 10 institutional shareholders own together 0.18% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CHI ADVISORS LLC0.01%11.87%5,255,484-237,409-4.32%44,724,170,000Mar 31, 2023
TCG CROSSOVER MANAGEMENT, LLC0.01%5.16%3,113,600780,30033.44%26,496,736,000Mar 31, 2023
CAXTON CORP0.00%3.40%156,6514290.27%1,345,549,000Mar 31, 2023
VR ADVISER, LLC0.00%3.10%1,866,000--15,879,660,000Mar 31, 2023
NOVO HOLDINGS A/S0.01%2.03%3,610,461270,9778.11%30,725,023,000Mar 31, 2023
CORMORANT ASSET MANAGEMENT, LP0.01%1.42%2,536,617--21,587,000Mar 31, 2023
VIVO CAPITAL, LLC0.01%1.38%2,333,300--19,856,383,000Mar 31, 2023
ORBIMED ADVISORS LLC0.01%0.86%5,156,561-1,850,300-26.41%43,882,334,000Mar 31, 2023
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.0.00%0.84%1,352,19918,7991.41%11,628,911,000Mar 31, 2023
BPIFRANCE SA0.01%0.61%2,806,217--23,880,907,000Mar 31, 2023
EVENTIDE ASSET MANAGEMENT, LLC0.01%0.58%3,675,644270,0007.93%31,610,538,000Mar 31, 2023
REGENCY CAPITAL MANAGEMENT INC.\DE0.00%0.39%38,00038,000100.00%323,380,000Mar 31, 2023
CANAAN PARTNERS XI LLC0.10%0.23%37,051--315,304,000Mar 31, 2023
TEKLA CAPITAL MANAGEMENT LLC0.00%0.22%682,834-54,870-7.44%5,872,372,000Mar 31, 2023
DRIEHAUS CAPITAL MANAGEMENT LLC0.00%0.21%1,768,19851,5423.00%15,206,503,000Mar 31, 2023
PFM HEALTH SCIENCES, LP0.00%0.05%131,922106,381416.51%1,122,656,000Mar 31, 2023
BLACKSTONE INC.0.00%0.05%1,333,333--11,466,664,000Mar 31, 2023
VALUES FIRST ADVISORS, INC.-0.04%8,1128,112100.00%69,031,000Mar 31, 2023
OCTAGON CAPITAL ADVISORS LP0.00%0.04%35,25935,259100.00%300,054,000Mar 31, 2023
MARSHALL WACE, LLP0.00%0.03%1,669,656300,00021.90%14,359,042,000Mar 31, 2023

The largest VectivBio shareholder by % of total assets is CHI ADVISORS LLC. The company owns 5.26M shares of VectivBio (VECT), representing 11.87% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
TCG CROSSOVER MANAGEMENT, LLC0.01%5.16%3,113,600780,30033.44%26,496,736,000Mar 31, 2023
ADAGE CAPITAL PARTNERS GP, L.L.C.0.00%0.01%409,100409,100100.00%3,481,441,000Mar 31, 2023
MARSHALL WACE, LLP0.00%0.03%1,669,656300,00021.90%14,359,042,000Mar 31, 2023
NOVO HOLDINGS A/S0.01%2.03%3,610,461270,9778.11%30,725,023,000Mar 31, 2023
EVENTIDE ASSET MANAGEMENT, LLC0.01%0.58%3,675,644270,0007.93%31,610,538,000Mar 31, 2023
PFM HEALTH SCIENCES, LP0.00%0.05%131,922106,381416.51%1,122,656,000Mar 31, 2023
WALLEYE CAPITAL LLC0.00%0.01%104,819104,819100.00%901,443,000Mar 31, 2023
GILDER GAGNON HOWE & CO LLC0.00%0.01%56,13756,137100.00%477,726,000Mar 31, 2023
DRIEHAUS CAPITAL MANAGEMENT LLC0.00%0.21%1,768,19851,5423.00%15,206,503,000Mar 31, 2023
REGENCY CAPITAL MANAGEMENT INC.\DE0.00%0.39%38,00038,000100.00%323,380,000Mar 31, 2023
BANK OF AMERICA CORP /DE/0.00%-39,74135,353805.67%338,196,000Mar 31, 2023
OCTAGON CAPITAL ADVISORS LP0.00%0.04%35,25935,259100.00%300,054,000Mar 31, 2023
GOLDMAN SACHS GROUP INC0.00%-27,07727,077100.00%230,425,000Mar 31, 2023
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.0.00%0.84%1,352,19918,7991.41%11,628,911,000Mar 31, 2023
VALUES FIRST ADVISORS, INC.-0.04%8,1128,112100.00%69,031,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC0.00%-24,6471,5936.91%211,964,000Mar 31, 2023
CAXTON CORP0.00%3.40%156,6514290.27%1,345,549,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)-0.00%277277100.00%2,000Mar 31, 2023
MORGAN STANLEY--2,262--19,250,000Mar 31, 2023
WELLS FARGO & COMPANY/MN--4,190--35,657,000Mar 31, 2023

As of Mar 31 2023, VectivBio's largest institutional buyer is TCG CROSSOVER MANAGEMENT, LLC. The company purchased 780.30K stocks of VECT, valued at $26.50B.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ORBIMED ADVISORS LLC0.01%0.86%5,156,561-1,850,300-26.41%43,882,334,000Mar 31, 2023
CHI ADVISORS LLC0.01%11.87%5,255,484-237,409-4.32%44,724,170,000Mar 31, 2023
UBS GROUP AG0.00%0.00%56,120-197,757-77.89%477,582,000Mar 31, 2023
NATIONAL BANK OF CANADA /FI/----165,333-100.00%-Mar 31, 2023
TEKLA CAPITAL MANAGEMENT LLC0.00%0.22%682,834-54,870-7.44%5,872,372,000Mar 31, 2023
BALYASNY ASSET MANAGEMENT L.P.0.00%0.01%322,418-20,866-6.08%2,772,795,000Mar 31, 2023
JANE STREET GROUP, LLC----19,233-100.00%-Mar 31, 2023
CITIGROUP INC0.00%0.00%80,474-802-0.99%692,076,000Mar 31, 2023
CITADEL ADVISORS LLC0.01%0.01%3,967,537-298-0.01%34,120,818,000Mar 31, 2023
VR ADVISER, LLC0.00%3.10%1,866,000--15,879,660,000Mar 31, 2023
CORMORANT ASSET MANAGEMENT, LP0.01%1.42%2,536,617--21,587,000Mar 31, 2023
VIVO CAPITAL, LLC0.01%1.38%2,333,300--19,856,383,000Mar 31, 2023
BPIFRANCE SA0.01%0.61%2,806,217--23,880,907,000Mar 31, 2023
CANAAN PARTNERS XI LLC0.10%0.23%37,051--315,304,000Mar 31, 2023
BLACKSTONE INC.0.00%0.05%1,333,333--11,466,664,000Mar 31, 2023
BARCLAYS PLC--9,407--80,000Mar 31, 2023
WELLS FARGO & COMPANY/MN--4,190--35,657,000Mar 31, 2023
MORGAN STANLEY--2,262--19,250,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)-0.00%277277100.00%2,000Mar 31, 2023
CAXTON CORP0.00%3.40%156,6514290.27%1,345,549,000Mar 31, 2023

As of Mar 31 2023, VectivBio's biggest institutional seller is ORBIMED ADVISORS LLC. The company sold -1.85M shares of VECT, valued at $43.88B.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ADAGE CAPITAL PARTNERS GP, L.L.C.0.00%0.01%409,100409,100100.00%3,481,441,000Mar 31, 2023
WALLEYE CAPITAL LLC0.00%0.01%104,819104,819100.00%901,443,000Mar 31, 2023
GILDER GAGNON HOWE & CO LLC0.00%0.01%56,13756,137100.00%477,726,000Mar 31, 2023
REGENCY CAPITAL MANAGEMENT INC.\DE0.00%0.39%38,00038,000100.00%323,380,000Mar 31, 2023
OCTAGON CAPITAL ADVISORS LP0.00%0.04%35,25935,259100.00%300,054,000Mar 31, 2023
GOLDMAN SACHS GROUP INC0.00%-27,07727,077100.00%230,425,000Mar 31, 2023
VALUES FIRST ADVISORS, INC.-0.04%8,1128,112100.00%69,031,000Mar 31, 2023
TOWER RESEARCH CAPITAL LLC (TRC)-0.00%277277100.00%2,000Mar 31, 2023

VectivBio's largest new institutional shareholder by number of shares is ADAGE CAPITAL PARTNERS GP, L.L.C., purchased 409.10K shares, valued at $3.48B, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NATIONAL BANK OF CANADA /FI/----165,333-100.00%-Mar 31, 2023
JANE STREET GROUP, LLC----19,233-100.00%-Mar 31, 2023

VectivBio's largest sold out institutional shareholder by shares sold is NATIONAL BANK OF CANADA /FI/, sold -0.17M shares, valued at -, as of undefined.

VectivBio Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
DRIEHAUS MUTUAL FUNDS0.01%41,549--Dec 29, 2023
NEXPOINT FUNDS I0.00%8,351--Dec 31, 2023
MUTUAL FUND SERIES TRUST0.00%3,675,644--Dec 31, 2023
Brinker Capital Destinations Trust0.00%63,298--Feb 29, 2024
RBB FUND, INC.0.00%32,201--Feb 29, 2024
COLUMBIA FUNDS SERIES TRUST I0.00%69,979--Feb 29, 2024

VectivBio's largest mutual fund holder by % of total assets is "DRIEHAUS MUTUAL FUNDS", owning 41.55K shares, compromising 0.01% of its total assets.

VectivBio Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 235355.88%
31 Mar, 233421.43%
31 Dec, 222833.33%
30 Sep, 22215.00%
30 Jun, 222025.00%
31 Mar, 2216-20.00%
31 Dec, 2120-13.04%
30 Sep, 2123-4.17%
30 Jun, 2124-

As of 30 Jun 23, 53 institutions are holding VectivBio's shares, representing an increase of 55.88% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2329,773,722-30.23%
31 Mar, 2342,671,305-0.08%
31 Dec, 2242,704,01852.62%
30 Sep, 2227,980,4000.41%
30 Jun, 2227,865,59419.39%
31 Mar, 2223,339,2320.28%
31 Dec, 2123,273,975-1.88%
30 Sep, 2123,721,0761.87%
30 Jun, 2123,284,739-

VectivBio (VECT) has 29.77M shares outstanding as of 30 Jun 23, down -30.23% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2367.47%0.72%
31 Mar, 2396.70%1.03%
31 Dec, 2296.78%2.41%
30 Sep, 2263.41%0.59%
30 Jun, 22103.37%1.38%
31 Mar, 2286.58%1.16%
31 Dec, 2186.34%1.12%
30 Sep, 2188.00%1.18%
30 Jun, 2186.38%-

As of 30 Jun 23, VectivBio is held by 67.47% institutional shareholders, representing a 0.72% growth compared to 31 Mar 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2342133.33%
31 Mar, 231812.50%
31 Dec, 2216128.57%
30 Sep, 227-36.36%
30 Jun, 2211120.00%
31 Mar, 225-44.44%
31 Dec, 219-
30 Sep, 219-62.50%
30 Jun, 2124-

42 institutional shareholders have increased their position in VECT stock as of 30 Jun 23 compared to 18 in the previous quarter (a 133.33% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 235-28.57%
31 Mar, 23740.00%
31 Dec, 225-16.67%
30 Sep, 22650.00%
30 Jun, 224-33.33%
31 Mar, 226-
31 Dec, 216-14.29%
30 Sep, 217-
30 Jun, 21--

5 institutional shareholders have reduced their position in VECT stock as of 30 Jun 23 compared to 7 in the previous quarter (a -28.57% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 235355.88%29,773,722-30.23%67.47%0.72%42133.33%5-28.57%
31 Mar, 233421.43%42,671,305-0.08%96.70%1.03%1812.50%740.00%
31 Dec, 222833.33%42,704,01852.62%96.78%2.41%16128.57%5-16.67%
30 Sep, 22215.00%27,980,4000.41%63.41%0.59%7-36.36%650.00%
30 Jun, 222025.00%27,865,59419.39%103.37%1.38%11120.00%4-33.33%
31 Mar, 2216-20.00%23,339,2320.28%86.58%1.16%5-44.44%6-
31 Dec, 2120-13.04%23,273,975-1.88%86.34%1.12%9-6-14.29%
30 Sep, 2123-4.17%23,721,0761.87%88.00%1.18%9-62.50%7-
30 Jun, 2124-23,284,739-86.38%-24---

VectivBio Peer Ownership


TickerCompany
ZURAZura Bio Limited
ZVSAZyVersa Therapeutics, Inc.
CNSPCNS Pharmaceuticals, Inc.
CWBRCohBar, Inc.
ELEVElevation Oncology, Inc.
IMMXImmix Biopharma, Inc.
OCEAOcean Biomedical, Inc.
EFTReFFECTOR Therapeutics, Inc.
ENVBEnveric Biosciences, Inc.
AVROAVROBIO, Inc.
HEPAHepion Pharmaceuticals, Inc.

VECT Ownership FAQ


VectivBio is owned by institutional shareholders (67.47%), insiders (4.50%), and public (28.03%). The largest institutional shareholder of VectivBio is CANAAN PARTNERS XI LLC (0.10% of total shares) and the top mutual fund owner is DRIEHAUS MUTUAL FUNDS (0.01% of total shares).

VectivBio's major institutional shareholders are CANAAN PARTNERS XI LLC, CHI ADVISORS LLC, ORBIMED ADVISORS LLC, CITADEL ADVISORS LLC, and EVENTIDE ASSET MANAGEMENT, LLC. The top five shareholders own together 0.15% of the company's share outstanding.

As of Jun 2023, there are 53 institutional shareholders of VectivBio.

CANAAN PARTNERS XI LLC owns 37.05K shares of VectivBio, representing 0.10% of the company's total shares outstanding, valued at $315.3M (as of Mar 2023).

As of Mar 2023, CHI ADVISORS LLC holds 5.26M shares of VectivBio (VECT), compromising 0.01% of the company, valued at $44.72B.

ORBIMED ADVISORS LLC is the third largest holder of VectivBio. The company owns 5.16M of the company's shares outstanding (worth $43.88B).